Skip to main content

Usage of New, Long Acting Theophyllines in the Management of Asthma

Buy Article:

$39.50 plus tax (Refund Policy)


A comprehensive review of the mechanism and treatment modality for bronchial asthma is presented. The pharmacokinetics of theophylline and the complications and side effects occuring when the therapeutic range of safety is exceeded is given along with the external factors involved with inter and intra-patient variability. Finally, a new zero order absorption theophylline preparation of a unique matrix dissolution system accounting for its constant release and bioavailability is discussed with emphasis on its safety and economy.

Document Type: Research Article


Affiliations: Chicago Medical School

Publication date: 1983-09-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more